Filing Flows › Comparisons › TGTX vs ZYME
TG Therapeutics vs Zymeworks: TGTX and ZYME compared
TG Therapeutics is the larger company: $260M of revenue in its latest quarter (Q3 2026) against $256M for Zymeworks (Q3 2026). Zymeworks is growing faster (+829% against +61% a year earlier). Zymeworks is more profitable, with an operating margin of 69.2% against 33.0%.
Where the money goes: TGTX and ZYME
TG Therapeutics (TGTX) · Q3 2026
TG Therapeutics, Q3 2026: revenue $260M (+61% year over year), operating margin 33.0%, net earnings $55.5M, operating cash flow $45.2M. The chart follows the revenue to costs, profit and cash.
Zymeworks (ZYME) · Q3 2026
Zymeworks, Q3 2026: revenue $256M (+829% year over year), operating margin 69.2%, net earnings $174M, operating cash flow −$24.0M. The chart follows the revenue to costs, profit and cash.
| TG Therapeutics (TGTX) | Zymeworks (ZYME) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $260M | $256M |
| Revenue growth, Y/Y | +61% | +829% |
| Operating margin | 33.0% | 69.2% |
| Net earnings | $55.5M | $174M |
| Net margin | 21.3% | 67.7% |
| Operating cash flow | $45.2M | −$24.0M |
| Free cash flow | $44.9M | — |
| Market value | $8.7B | $1.9B |
| P/E | 19.7× | — |
| Analysts’ mean target | $69.71 | $41.50 |
Where the revenue comes from
TG Therapeutics
- Product revenue, net: $240M (92%)
- License, milestone, royalty and other revenue: $19.9M (8%)
Zymeworks
- License and milestone revenue: $250M (97%)
- Royalty and other revenue: $4.9M (2%)
- Viatris collaboration agreement revenue: $1.5M (1%)
Questions
Which is bigger, TG Therapeutics or Zymeworks?
TG Therapeutics is the larger company: $260M of revenue in its latest quarter (Q3 2026) against $256M for Zymeworks (Q3 2026).
Is TG Therapeutics or Zymeworks growing faster?
Zymeworks is growing faster (+829% against +61% a year earlier).
Which is more profitable, TG Therapeutics or Zymeworks?
Zymeworks is more profitable, with an operating margin of 69.2% against 33.0%.
More: TG Therapeutics earnings · how TG Therapeutics makes money · Zymeworks earnings · how Zymeworks makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.